Open·Ingested 291 days ago, not re-verified since

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

National Institutes of Health

Apply at National Institutes of Health

Free. Verify your email, then we send one reminder only.

Posted: Oct 23, 2025
Closes: Jul 5, 2029 (in 1059 days)

Similar opportunities open now

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses May 2029
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses May 2029
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)OpenNational Institutes of HealthCloses Apr 2029
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jul 2029Up to $500K
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)OpenNational Institutes of HealthCloses Oct 2027

Classification and identifiers

Solicitation number: PAR-27-064
Assistance listing (CFDA): 93.855

Amount

Amount not published by the funder

Who can apply

School districtsNonprofits (non-501c3)Small businessCounty governmentsTribal organizationsNonprofits

Small businesses and Nonprofits, including small and volunteer-run organizations can all apply here. Check the eligibility details below to see if your organization fits.

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

About this opportunity

This notice of funding opportunity (NOFO) encourages applications for implementation of investigator-initiated, milestone driven clinical trials that need enhanced oversight, and as applicable, include mechanistic studies. Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities. Support is available for clinical trials up to 5 years, as well as for extended clinical trials of 6- or 7-years.Investigators are encouraged to visit this NIH website for additional information about the overall mission and research areas of NIAID.Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation Cooperative Agreement (U01) application. In accordance with NIH standard pee...